Technology, media & communications
Click here to find out more
Future Fund: update to connected person test following Taylor Wessing (and others) request for changes
9 July 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
23 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss
Life sciences & healthcare
Click here to find out more
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
22 June 2020
IN-DEPTH ANALYSIS
by Adrian Toutoungi and Josef Fuss
Technology, media & communications
Click here to find out more
Future Fund: a recent change will reduce the universe of eligible companies – is a fix on its way?
12 June 2020
IN-DEPTH ANALYSIS
by multiple authors
Technology, media & communications
Click here to find out more
Webinar: What you need to know about the UK Government's new Future Fund 2.0
9 June 2020
QUICK READ
by multiple authors
Synapse
Click here to find out more
COVID-19 postponement of MDR implementation date – how does this fit with Brexit?
26 May 2020
IN-DEPTH ANALYSIS
Coronavirus
Click here to find out more
What you need to know about the UK Government's new Future Fund 2.0
19 May 2020
IN-DEPTH ANALYSIS
by multiple authors
Environmental, planning & regulatory
Click here to find out more
Hope for compensation for Corona-related plant closures increases
15 May 2020
Life sciences & healthcare
Click here to find out more
Everything biologic and biosimilar in-house counsel need to know about COVID-19
29 April 2020
by multiple authors
Coronavirus
Click here to find out more
What you need to know about the UK government's new Future Fund
27 April 2020
IN-DEPTH ANALYSIS
by multiple authors
Synapse
Click here to find out more
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
22 April 2020
IN-DEPTH ANALYSIS